|
|
 |
 |
Search Results for: R |
 |
|
 |
|
|
 |
| 31 |
(3R)-3-[(1,1-dimethyl ethoxy carbonyl)amino]-4-(2,4,5-trifluorophenyl butanoic acid
Manus Aktteva offers Sitagliptin Intermediate, (3R)-3-[(1,1-dimethyl ethoxy carbonyl)amino]-4-(2,4,5-trifluorophenyl butanoic acid, 486460-00-8, for RND for your evaluation, pilots and commercial requirements with supportive technical package require....
View Detail
|
 |
|
|
| 32 |
(4R)-3-[(2S)-3-Methyl-1-oxo-2-[(phenylmethoxy)methyl]butyl]-4-(phenylmethyl)-2-oxazolidinone
Manus Aktteva offers Aliskiren hemifumarate Intermediate,(4R)-3-[(2S)-3-Methyl-1-oxo-2-[(phenylmethoxy)methyl]butyl]-4-(phenylmethyl)-2-oxazolidinone, 365541-74-8,for your requirements of RND, evaluation, pilots and commercial along with supportive t....
View Detail
|
 |
|
|
| 33 |
(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester
Manus Aktteva offers 149809-43-8, Intermediate of Posaconazole, (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester, for your requirements of RND, evaluation, pilots and commercial a....
View Detail
|
 |
|
|
| 34 |
(R)-(+)-1-(1-Naphthyl)ethylamine
Manus Aktteva offers Cinacalcet Intermediate, (R)-(+)-1-(1-Naphthyl)ethylamine, 3886-70-2, for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 35 |
(R)-(-)-1-Aminoindane hydrochloride
Manus Aktteva offers Rasagiline mesylate Intermediate,10305-73-4, (R)-(-)-1-Aminoindane hydrochloride,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 36 |
(R)-(-)-1-Chloro-2,3-epoxypropane
Manus Aktteva offers Rivaroxaban Intermediate, 51594-55-9, 2-(Chloromethyl)oxirane, (R)-(-)-1-Chloro-2,3-epoxypropane,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 37 |
(R)-(-)-4-Benzyloxy-3-(3-diisopropylamino-1-phenylpropyl)-benzoic acid
Manus Aktteva offers Intermediate of Fesoterodine, (R)-(-)-4-Benzyloxy-3-(3-diisopropylamino-1-phenylpropyl)-benzoic acid, 754159-68-7 for your requirements along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 38 |
(R)-1-[3,5-Bistrifluoromethylphenyl]ethanol
Manus Aktteva offers Aprepitant Intermediate, (R)-1-[3,5-Bistrifluoromethylphenyl]ethanol, 127852-28-2, for RND for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 39 |
(R)-2-Amino-3-methoxypropanoic acid hydrochloride
Manus Aktteva offers 86118-10-7, O-Methyl-D-serine.HCl amongst the various Intermediates of Lacosamide for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 40 |
(R)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl piperidin-1-yl]propanoic acid
Manus Aktteva offers Alvimopan intermediate,156130-41-5, (R)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl piperidin-1-yl]propanoic acid, for your evaluation,pilots and commercial requirements with supportive technical package required for eva....
View Detail
|
 |
|
|
| 41 |
(R)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl piperidin-1-yl]propanoic acid methyl ester
Manus Aktteva offers Alvimopan intermediate,170098-29-0, (R)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl piperidin-1-yl]propanoic acid methyl ester, for your evaluation,pilots and commercial requirements with supportive technical package req....
View Detail
|
 |
|
|
| 42 |
(R)-2-Methyl-CBS-Oxazaborolidine,1M in toluene
Manus Aktteva offers Aprepitant Intermediate, 112022-83-0, (R)-2-Methyl-CBS-Oxazaborolidine, 1M in toluene, for RND for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 43 |
(R)-4-(2-(chloromethyl)-3-methylbutyl)-1-methoxy-2-(3-methoxypropoxy)benzene
Manus Aktteva offers Aliskiren hemifumarate and its Intermediate (R)-4-(2-(chloromethyl)-3-methylbutyl)-1-methoxy-2-(3-methoxypropoxy)benzene, 324763-39-5, for your evaluation, pilots and commercial requirements with supportive technical package requ....
View Detail
|
 |
|
|
| 44 |
(R)-5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole
Manus Aktteva offers Eletriptan Hydrobromide and its intermediate, (R)-5-bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indole, 143322-57-0 for your evaluation, pilots and commercial requirements with supportive technical package required for evaluatio....
View Detail
|
 |
|
|
| 45 |
(R)-BoroLeu-(+)-Pinanediol-CF3COOH
Manus Aktteva offers Bortezomib Intermediate, (R)-BoroLeu-(+)-Pinanediol-CF3COOH, 179324-87-9, for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|